>
Is Big Pharma Selling Postpartum Depression to New Moms?
Make Men Men Again: Low T Is Now a National Defense Problem
Druski: They're Lying To You About Overnight Success!
$6.27 Diesel Just Hit Harvest. The Grocery Aisle Hasn't Felt It Yet.
Tesla Model 3 killer charges from 10 to 97% in just 9 minutes
World-first unpowered DNA computer sets speed record
I Power 5 Buildings Off-Grid. Here's How
The US government is pushing hard to get a working nuclear fission reactor into space by late 2028
SpaceX Starmind AI in Space Radiator
China Will Dominate Global Nuclear Energy Through 2035, Analyst Says
These Absolutely Wild-Looking EVs Are Saudi Arabia's First Homegrown Cars
BEYOND THE MOON: NASA plans a nuclear-powered fleet to push DEEPER into space
Big Oil Backs Mazama's $135 Million Bet On Superhot Geothermal

With promising early results, the researchers say their findings could usher in trials where such transplantations are put to the test in humans.
Stem cells have shown exciting potential in improving the vision of patients with degenerative eye disorders for years. In 2010, scientists reported the creation of the first early-stage retina engineered with human embryonic stem cells. Then in 2012, two legally blind patients experienced improvements to their vision after receiving transplants of retinal cells, also derived from human embryonic stem cells.
But what sets this latest achievement apart is that scientists from Osaka and Cardiff University's were able to use human stem cells to reproduce something closer to the complex nature of the entire eyeball. Using induced pluripotent stem cells, or cells derived directly from adult cells, they were able to cultivate multiple cell lineages of the eye, including the lens, cornea and conjunctiva.